 |
|
Molecular imaging sheds new light on progression of Alzheimer's disease
June 17, 2008Research following path of brain degeneration announced at SNM's 55th Annual Meeting, June 14-18
New Orleans, La.-In the past, physicians were able only to follow the progression of Alzheimer's disease (AD) through careful clinical histories, noting the often subtle changes associated with cognitive decline over a number of years. Recent research suggests that the use of molecular imaging in the management of neurodegenerative disease, particularly for early diagnosis of AD, will enable researchers to monitor the progression of the disease, identifying those at risk and assessing the effectiveness of new therapies.
Some studies have suggested that the characteristic signs of AD are present up to a decade before dementia sets in. The difficulty was being able to look into a living person's brain to see the deposits of plaque (an abnormal accumulation of insoluble fibrous beta-amyloid protein aggregates) thought to be responsible for the onset of the disease.
Using positron emission tomography (PET) and a radiotracer known as Pittsburgh Compound-B (PiB) that is capable of binding to plaques found in the brains of AD patients, researchers at the University of Pittsburgh found that beta-amyloid imaging could provide early detection of AD and more accurate differential diagnosis of other dementias (by revealing the presence or absence of beta-amyloid plaques).
In a current longitudinal study following participants for more than four years, the Pittsburgh research team has recently sought to compare patients with AD to elderly control individuals and to subjects with mild cognitive impairment (MCI) to determine control subjects at risk of developing cognitive impairment and those MCI subjects who were most likely to progress on to a clinical diagnosis of AD. Thirty-five people (four with mild to moderate AD, 10 with MCI and 21 elderly controls) were scanned at yearly intervals over four years.
"The research literature shows that 30 to 40 percent of people with MCI do not progress to AD during five to 10 years of follow-up testing. Our hypothesis was that MCI subjects with brain plaque would develop AD and MCI subjects without plaque would not advance to AD," said Chester Mathis, Ph.D., professor of radiology at the University of Pittsburgh. "We found that about 60 percent of the MCI subjects had plaque loads comparable to AD subjects, while about 35 percent of MCI subjects had no detectable plaque. After monitoring our study MCI participants for four years, we have found that only those with plaque progressed on to the clinical diagnosis of AD. In AD subjects, there appears to be a ceiling to plaque deposition, and plaque concentration does not increase as the disease progresses from mild to advanced stages of AD," he said.
"We had also assumed that the elderly control group would have little PiB retention (indicating no amyloid deposits), but the results were otherwise," he added. "We found that about 25 percent of participants between 65 and 80 years of age had significant deposits of amyloid plaque in their brains. We hypothesize that these control subjects are in a presymptomatic, at-risk state that will eventually lead to AD."
Dementia is a general term for a progressive brain dysfunction that results in the loss of memory and other intellectual abilities serious enough to interfere with daily life. MCI patients demonstrate a decline of cognitive performance that is more pronounced than expected from age but not severe enough to meet criteria for the clinical diagnosis of dementia. The clinical course of these patients is challenging to forecast on the basis of clinical measures alone. Many diseases can result in a form of dementia, the most common one being AD, a progressive and fatal brain disease. According to the Alzheimer's Association, more than five million people in the United States have AD, and by 2050, that number could triple. Currently it is the seventh leading cause of death in the United States.
Society of Nuclear Medicine
Using positron emission tomography (PET) and a radiotracer known as Pittsburgh Compound-B (PiB) that is capable of binding to plaques found in the brains of AD patients, researchers at the University of Pittsburgh found that beta-amyloid imaging could provide early detection of AD and more accurate differential diagnosis of other dementias (by revealing the presence or absence of beta-amyloid plaques).
In a current longitudinal study following participants for more than four years, the Pittsburgh research team has recently sought to compare patients with AD to elderly control individuals and to subjects with mild cognitive impairment (MCI) to determine control subjects at risk of developing cognitive impairment and those MCI subjects who were most likely to progress on to a clinical diagnosis of AD. Thirty-five people (four with mild to moderate AD, 10 with MCI and 21 elderly controls) were scanned at yearly intervals over four years.
"The research literature shows that 30 to 40 percent of people with MCI do not progress to AD during five to 10 years of follow-up testing. Our hypothesis was that MCI subjects with brain plaque would develop AD and MCI subjects without plaque would not advance to AD," said Chester Mathis, Ph.D., professor of radiology at the University of Pittsburgh. "We found that about 60 percent of the MCI subjects had plaque loads comparable to AD subjects, while about 35 percent of MCI subjects had no detectable plaque. After monitoring our study MCI participants for four years, we have found that only those with plaque progressed on to the clinical diagnosis of AD. In AD subjects, there appears to be a ceiling to plaque deposition, and plaque concentration does not increase as the disease progresses from mild to advanced stages of AD," he said.
"We had also assumed that the elderly control group would have little PiB retention (indicating no amyloid deposits), but the results were otherwise," he added. "We found that about 25 percent of participants between 65 and 80 years of age had significant deposits of amyloid plaque in their brains. We hypothesize that these control subjects are in a presymptomatic, at-risk state that will eventually lead to AD."
Dementia is a general term for a progressive brain dysfunction that results in the loss of memory and other intellectual abilities serious enough to interfere with daily life. MCI patients demonstrate a decline of cognitive performance that is more pronounced than expected from age but not severe enough to meet criteria for the clinical diagnosis of dementia. The clinical course of these patients is challenging to forecast on the basis of clinical measures alone. Many diseases can result in a form of dementia, the most common one being AD, a progressive and fatal brain disease. According to the Alzheimer's Association, more than five million people in the United States have AD, and by 2050, that number could triple. Currently it is the seventh leading cause of death in the United States.
Society of Nuclear Medicine
Molecular Imaging News and Current Molecular Imaging Events RSSPET scans lead to treatment changes in majority of colorectal cancer patients
In the largest multi-institutional study to date examining the impact of positron emission tomography (PET) in changing disease management of individuals with suspected recurrent colorectal cancer, researchers found that treatment plans were changed for more than half of patients.
Fair and adequate reimbursement is vital to developing life-saving medical treatments
Reimbursement of molecular imaging and therapies-leading to the early detection and diagnosis of many life-threatening diseases-remains an urgent and critical need as consumers face ever-increasing healthcare costs.
Ability to track stem cells in tumors could advance cancer treatments
Using noninvasive molecular imaging technology, a method has been developed to track the location and activity of mesenchymal stem cells (MSCs) in the tumors of living organisms.
New possibilities for breast cancer treatment on the horizon
he first patient scans from a custom-built scanner combining positron emission tomography (PET) and computed tomography (CT) technologies indicate that these scans could significantly improve breast cancer imaging capabilities and lead to more targeted treatment options, according to researchers at SNM's 55th Annual Meeting.
First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease
Evaluations of the first-ever prototype positron emission tomography (PET) brain scanner that uses semiconductor detectors indicate that the scanner could advance the quality and spatial resolution of PET imaging, according to researchers at SNM's 55th Annual Meeting.
New study shows potential to treat or prevent viral cancers
A new study, presented at the SNM 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat-or even prevent-many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy.
Study recommends development of standards for pediatric doses in nuclear medicine
Results of a recent survey of 13 pediatric hospitals in North America show a lack of universally applied standards for administering radiopharmaceutical doses to children undergoing nuclear medicine examinations, according to an article in the June issue of The Journal of Nuclear Medicine.
Power of Molecular Imaging Reveals Secrets of the Heart
The extraordinary action of a new cellular therapy came to light as a result of powerful PET and SPECT imaging in a recent study reported in the April issue of the Journal of Nuclear Medicine.
Protein shines light on cancer response
A technique that specifically "tags" tumors responding to chemotherapy may offer a new strategy for determining a cancer treatment's effectiveness within days of starting treatment, according to a new study by Vanderbilt-Ingram Cancer Center investigators.
PET/CT Imaging Proves Golden for Detecting Cancer in Children
PET/CT imaging exhibits significantly higher sensitivity, specificity and accuracy than conventional imaging when it comes to detecting malignant tumors in children.
More Molecular Imaging News Articles
 | Foundations of Image Science by Harrison H. Barrett, Kyle Myers Winner of the 2006 Joseph W. Goodman Book Writing Award! A comprehensive treatment of the principles, mathematics, and statistics of image science In today’s visually oriented society, images play an important role in conveying messages. From seismic imaging to satellite images to medical images, our modern society would be lost without images to enhance our understanding of... |
 | Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (TIETZ TEXTBOOK OF CLINICAL CHEMISTRY ( BURTIS)) by Carl A. Burtis, Edward R. Ashwood, David E. Bruns Bridging the gap between the clinical laboratory and medical management by relating pathophysiology to analytical results in health and disease, this classic resource provides the guidance necessary to select, perform, and evaluate the results of new and established laboratory tests. Its up-to-date, encyclopedic coverage of the field defines analytical criteria for the medical usefulness of... |
 | Molecular Anatomic Imaging: PET-CT and SPECT-CT Integrated Modality Imaging This fully updated Second Edition is perfect for clinicians, as it focuses sharply on clinical PET-CT and SPECT-CT examinations, omitting lengthy physics discussions. The book is now strictly disease oriented and integrates PET-CT and SPECT-CT applications completely. When both techniques are relevant for a disease, they are discussed together; when only one is relevant, it is discussed alone.... |
 | Three-Dimensional Electron Microscopy of Macromolecular Assemblies: Visualization of Biological Molecules in Their Native State by Joachim Frank Cryoelectron microscopy of biological molecules is among the hottest growth areas in biophysics and structural biology at present, and Frank is arguably the most distinguished practitioner of this art. CryoEM is likely over the next few years to take over much of the structural approaches currently requiring X-ray crystallography, because one can now get good and finely detailed images of single... |
 | Clinical Molecular Anatomic Imaging: PET, PET/CT, and SPECT/CT Fusion imaging tomography (FIT, also called "functional anatomic mapping") describes an imaging study that combines radiology (form) and nuclear medicine (function). This is the first book on the subject and includes information on lesion detection, diagnosis, staging, and treatment. The book features experienced contributors from multiple international imaging centers, and four-color images... |
 | Imaging in Molecular Dynamics: Technology and Applications Written in a tutorial style by some of the key practitioners in the field, this book provides a comprehensive account of charged particle imaging and describes many of its recent applications. The technique has revolutionized experimental studies of photodissociation and bimolecular collisions over the past couple of decades. It is of primary interest to researchers and graduate students working... |
 | Microbial Imaging, Volume 34 (Methods in Microbiology) Recent advances in molecular technology have provided new microbial imaging tools, not only complementing more classical methods, but in many cases significantly enhancing the sensitivity and efficiency in which studies may be conducted. These technologies are applicable to a wide range of problems in contemporary microbiology, including strain selection, understanding microbial structure,... |
 | PET: Molecular Imaging and Its Biological Applications by Michael E. Phelps Michael E. Phelps is often called the "founder of PET" and the UCLA School of Medicine is recognized as one of the leading PET centers in the world. All of the contributors to this book are on the UCLA School of Medicine faculty; their combined areas of expertise enabled the creation of the premier reference book on PET. PET:Molecular Imaging and Its Biological Applications serves as a valuable... |
 | Anatomy of Gene Regulation: A Three-dimensional Structural Analysis by Panagiotis A. Tsonis Anatomy of Gene Regulation is the first book to present the parts and processes of gene regulation at the three-dimensional level. Vivid structures of nucleic acids and their companion proteins are revealed in full-color, three dimensional form. Beginning with a general introduction to three-dimensional structures, the book looks at the organization of the genome, the structure of DNA, DNA... |
 | Encyclopedia of Diagnostic Imaging The aim of this comprehensive encyclopedia is to provide detailed information on diagnostic radiology contributing to the broad field of imaging. The simple A to Z format provides easy access to relevant information. Extensive cross references between keywords and related articles enable efficient searches in a user-friendly manner. The wide range of entries will provide basic and clinical... |
| © 2008 BrightSurf.com |